retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight Retatrutide vs Semaglutide: Triple vs
Description
Health Dis
As with other incretin-based therapies, the most commonly reported adverse effects in the retatrutide phase 2 trial were gastrointestinal in nature
Combining strategic meal timing with the right macronutrient ratios can counteract this effect substantially
Typically once per day, but dosage can vary based on response and goals
